更多...
收起
This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]
[中文简述(自动翻译):]  
CDKN2A基因(以及对应的蛋白质)的细胞分布位置:
CDKN2A基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Melanoma astrocytoma syndrome | 0.360542884 | 2 | 0 | BeFree_CLINVAR_CTD_human_ORPHANET |
melanoma | 0.36 | 508 | 13 | BeFree_CTD_human_GAD_LHGDN |
MELANOMA-PANCREATIC CANCER SYNDROME | 0.36 | 1 | 2 | CLINVAR_CTD_human_UNIPROT |
Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.274751948 | 56 | 1 | BeFree_CTD_human_GAD_GWASCAT_LHGDN |
Liver carcinoma | 0.251944713 | 95 | 0 | BeFree_CTD_human_LHGDN_RGD |
Lung Neoplasms | 0.244655508 | 39 | 0 | BeFree_CTD_human_LHGDN_RGD |
MELANOMA, CUTANEOUS MALIGNANT, 2 | 0.24 | 10 | 1 | CTD_human_UNIPROT |
LI-FRAUMENI SYNDROME 1 | 0.24 | 1 | 0 | CTD_human_UNIPROT |
Esophageal Neoplasms | 0.221898372 | 25 | 0 | BeFree_CTD_human_GAD_LHGDN_RGD |
Mesothelioma | 0.219854983 | 38 | 0 | BeFree_CTD_human_LHGDN_RGD |
Stomach Neoplasms | 0.209987267 | 13 | 0 | BeFree_CTD_human_GAD_LHGDN_RGD |
Adenocarcinoma | 0.180217453 | 105 | 0 | BeFree_CTD_human_GAD_LHGDN |
Glioma | 0.17287254 | 105 | 8 | BeFree_CTD_human_GAD_LHGDN |
Mammary Neoplasms | 0.157687777 | 23 | 0 | BeFree_CTD_human_GAD_LHGDN |
Pancreatic Neoplasm | 0.153434465 | 21 | 0 | BeFree_CTD_human_GAD_LHGDN |
Non-Small Cell Lung Carcinoma | 0.150054103 | 104 | 0 | BeFree_CTD_human_GAD |
Lymphoma | 0.146555153 | 63 | 0 | BeFree_CTD_human_GAD_LHGDN |
Hereditary Melanoma | 0.145439591 | 86 | 10 | BeFree_CLINVAR_GAD |
Bladder Neoplasm | 0.144780663 | 21 | 0 | BeFree_CTD_human_LHGDN |
Squamous cell carcinoma | 0.144494883 | 219 | 1 | BeFree_GAD_LHGDN |
Cutaneous Melanoma | 0.143539498 | 80 | 2 | BeFree_CTD_human_GAD |
Squamous cell carcinoma of the head and neck | 0.139815257 | 74 | 0 | BeFree_CTD_human |
Brain Neoplasms | 0.135635346 | 21 | 3 | BeFree_CTD_human_GAD |
Multiple Myeloma | 0.13413484 | 33 | 0 | BeFree_CTD_human_LHGDN |
Squamous cell carcinoma of esophagus | 0.132681823 | 39 | 0 | BeFree_CTD_human_GAD |
Neuroblastoma | 0.129238955 | 25 | 0 | BeFree_CTD_human_LHGDN |
Nasopharyngeal carcinoma | 0.125971721 | 23 | 0 | BeFree_CTD_human |
Diffuse Large B-Cell Lymphoma | 0.125157396 | 20 | 0 | BeFree_CTD_human |
Adenocarcinoma Of Esophagus | 0.124614512 | 18 | 0 | BeFree_CTD_human |
Nerve Sheath Tumors | 0.124353001 | 8 | 0 | BeFree_CTD_human_LHGDN |
Carcinoma, Pancreatic Ductal | 0.123452799 | 6 | 0 | BeFree_CTD_human_GAD |
Pancreatic carcinoma, familial | 0.123257302 | 12 | 0 | BeFree_ORPHANET |
Sezary Syndrome | 0.12272435 | 2 | 0 | CTD_human_LHGDN |
Liver neoplasms | 0.122714419 | 12 | 0 | BeFree_CTD_human |
Lymphoma, T-Cell, Cutaneous | 0.120814326 | 4 | 0 | BeFree_CTD_human |
Vulvar Lichen Sclerosus | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Neoplastic Syndromes, Hereditary | 0.120542884 | 2 | 20 | BeFree_CLINVAR |
Thymoma | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Glaucoma | 0.120271442 | 1 | 0 | BeFree_CTD_human |
Adrenocortical carcinoma | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Adrenal Gland Neoplasms | 0.12 | 1 | 0 | CTD_human |
Neoplasm Invasiveness | 0.12 | 1 | 0 | CTD_human |
Peripheral Neuropathy | 0.12 | 2 | 0 | CTD_human |
Chromosomal translocation | 0.12 | 1 | 0 | CTD_human |
Genitourinary Neoplasms | 0.12 | 1 | 0 | CTD_human |
Brain Stem Neoplasms | 0.12 | 1 | 0 | CTD_human |
Micronuclei, Chromosome-Defective | 0.12 | 1 | 0 | CTD_human |
MELANOMA, CUTANEOUS MALIGNANT, 1 | 0.12 | 0 | 1 | CLINVAR |
LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 | 0.12 | 0 | 0 | ORPHANET |
Diabetes Mellitus, Non-Insulin-Dependent | 0.089771907 | 77 | 43 | BeFree_GAD |
Endometrial Neoplasms | 0.088173051 | 4 | 0 | LHGDN_RGD |
Rhabdomyosarcoma | 0.087620235 | 10 | 0 | BeFree_LHGDN_RGD |
Obesity | 0.085276948 | 5 | 0 | BeFree_GAD_RGD |
Hypertensive disease | 0.085005506 | 3 | 0 | BeFree_GAD_RGD |
Colonic Neoplasms | 0.08408156 | 7 | 0 | BeFree_LHGDN_RGD |
Kidney Neoplasm | 0.081357209 | 6 | 0 | BeFree_RGD |
Degenerative polyarthritis | 0.080814326 | 4 | 0 | BeFree_RGD |
Hyperplasia | 0.08 | 1 | 0 | RGD |
Mammary Neoplasms, Experimental | 0.08 | 1 | 0 | RGD |
Tongue Neoplasms | 0.08 | 2 | 0 | RGD |
Carcinogenesis | 0.08 | 309 | 1 | BeFree |
Oculopalatocerebral Syndrome | 0.08 | 0 | 0 | MGD |
Colorectal Neoplasms | 0.04649952 | 19 | 0 | BeFree_GAD_LHGDN |
Malignant neoplasm of breast | 0.043366024 | 93 | 20 | BeFree_GAD |
Skin Neoplasms | 0.042139637 | 24 | 0 | BeFree_GAD |
Malignant neoplasm of lung | 0.038316911 | 117 | 8 | BeFree_GAD |
Colorectal Cancer | 0.036188984 | 85 | 0 | BeFree_GAD |
Malignant neoplasm of pancreas | 0.034983664 | 95 | 1 | BeFree_GAD |
Neoplasm Metastasis | 0.033678655 | 106 | 0 | BeFree_LHGDN |
Carcinoma of lung | 0.029782661 | 101 | 8 | BeFree_GAD |
Retinoblastoma | 0.028511328 | 96 | 0 | BeFree_LHGDN |
Pancreatic carcinoma | 0.027958513 | 103 | 1 | BeFree |
Tumor Progression | 0.024158327 | 89 | 0 | BeFree |
Colorectal Carcinoma | 0.023615443 | 87 | 0 | BeFree |
Breast Carcinoma | 0.023344001 | 86 | 20 | BeFree |
Glioblastoma | 0.023277988 | 69 | 0 | BeFree_GAD_LHGDN |
Malignant neoplasm of urinary bladder | 0.022301841 | 58 | 4 | BeFree_GAD |
leukemia | 0.02219222 | 65 | 0 | BeFree_GAD_LHGDN |
Adenoma | 0.021483634 | 41 | 0 | BeFree_LHGDN |
Malignant neoplasm of ovary | 0.020792742 | 37 | 0 | BeFree_GAD |
Acute lymphocytic leukemia | 0.02035814 | 75 | 1 | BeFree |
ovarian neoplasm | 0.019974535 | 22 | 0 | BeFree_GAD_LHGDN |
Malignant neoplasm of stomach | 0.019391925 | 56 | 0 | BeFree_GAD |
Cervical Intraepithelial Neoplasia | 0.019030726 | 43 | 0 | BeFree_LHGDN |
Stomach Carcinoma | 0.016829396 | 62 | 0 | BeFree |
Leukemia, Myelocytic, Acute | 0.016501872 | 34 | 0 | BeFree_GAD_LHGDN |
Coronary heart disease | 0.016188161 | 10 | 11 | BeFree_GAD_LHGDN |
Cervix carcinoma | 0.01601507 | 59 | 0 | BeFree |
Astrocytoma | 0.01549205 | 38 | 1 | BeFree_LHGDN |
Carcinoma of bladder | 0.015472187 | 57 | 4 | BeFree |
Cancer of Head and Neck | 0.015244352 | 31 | 0 | BeFree_GAD |
Osteosarcoma | 0.014144772 | 23 | 0 | BeFree_LHGDN |
Malignant tumor of cervix | 0.014114977 | 52 | 0 | BeFree |
Meningioma | 0.013982951 | 16 | 0 | BeFree_GAD_LHGDN |
Renal Cell Carcinoma | 0.01387333 | 22 | 0 | BeFree_LHGDN |
Infection | 0.013621751 | 5 | 0 | LHGDN |
Myocardial Infarction | 0.013463811 | 10 | 2 | BeFree_GAD |
Mouth Neoplasms | 0.013178557 | 6 | 0 | BeFree_GAD_LHGDN |
Precancerous Conditions | 0.013148762 | 32 | 0 | BeFree_GAD |
Gastrointestinal Stromal Tumors | 0.012516121 | 18 | 0 | BeFree_LHGDN |
Hepatitis B | 0.012244679 | 15 | 0 | BeFree_LHGDN |
B-Cell Lymphomas | 0.012244679 | 17 | 0 | BeFree_LHGDN |
Coronary Artery Disease | 0.012182547 | 14 | 1 | BeFree_GAD |
Kidney Failure, Acute | 0.011400559 | 42 | 0 | BeFree |
Ovarian Carcinoma | 0.011400559 | 42 | 0 | BeFree |
Acute respiratory failure | 0.011400559 | 42 | 0 | BeFree |
Pituitary Neoplasms | 0.011158911 | 13 | 0 | BeFree_LHGDN |
Diabetes Mellitus | 0.011096779 | 9 | 0 | BeFree_GAD |
Barrett Esophagus | 0.01099709 | 6 | 0 | BeFree_GAD_LHGDN |
Secondary malignant neoplasm of lymph node | 0.010314791 | 38 | 0 | BeFree |
Actinic keratosis | 0.010073144 | 8 | 0 | BeFree_LHGDN |
Malignant neoplasm of esophagus | 0.00989146 | 21 | 0 | BeFree_GAD |
Adult T-Cell Lymphoma/Leukemia | 0.009424521 | 26 | 0 | BeFree_GAD |
Myeloid Leukemia, Chronic | 0.009238955 | 24 | 0 | BeFree_LHGDN |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.008967513 | 24 | 0 | BeFree_LHGDN |
Prostatic Neoplasms | 0.0089015 | 7 | 1 | BeFree_GAD_LHGDN |
Sarcoma | 0.008153188 | 21 | 0 | BeFree_LHGDN |
Ulcerative Colitis | 0.007891677 | 10 | 0 | BeFree_LHGDN |
Leukemia, Lymphocytic, Acute, L1 | 0.007871814 | 29 | 2 | BeFree |
Basal cell carcinoma | 0.007815732 | 3 | 0 | GAD_LHGDN |
Cerebrovascular accident | 0.00764398 | 4 | 0 | BeFree_GAD |
Carcinoma, Transitional Cell | 0.007610304 | 19 | 0 | BeFree_LHGDN |
Cholangiocarcinoma | 0.007534359 | 9 | 0 | BeFree_GAD_LHGDN |
Intracranial Aneurysm | 0.007372538 | 4 | 1 | BeFree_GAD |
Lip and Oral Cavity Carcinoma | 0.007252986 | 18 | 0 | BeFree_GAD |
Neoplasms, Multiple Primary | 0.007101096 | 3 | 0 | GAD |
Adenoid Cystic Carcinoma | 0.007077352 | 6 | 0 | BeFree_LHGDN |
Mixed Salivary Gland Tumor | 0.007077352 | 7 | 0 | BeFree_LHGDN |
Thyroid Neoplasm | 0.007077352 | 8 | 0 | BeFree_LHGDN |
Pancreatitis, Chronic | 0.007077352 | 6 | 0 | BeFree_LHGDN |
Melanocytic nevus | 0.00706742 | 17 | 2 | BeFree_LHGDN |
Embryonal Carcinoma | 0.007057489 | 26 | 0 | BeFree |
Dysplastic Nevus Syndrome | 0.006991475 | 8 | 0 | BeFree_GAD_LHGDN |
Nevus | 0.006905599 | 10 | 2 | BeFree_GAD |
Rhabdoid Tumor | 0.00680591 | 7 | 0 | BeFree_LHGDN |
High-Grade Squamous Intraepithelial Lesions | 0.006786047 | 25 | 0 | BeFree |
Dysplastic Nevus | 0.006710102 | 16 | 1 | BeFree_GAD |
Hodgkin Disease | 0.006534468 | 6 | 0 | BeFree_LHGDN |
Mycosis Fungoides | 0.006534468 | 5 | 0 | BeFree_LHGDN |
Hematologic Neoplasms | 0.006524536 | 15 | 0 | BeFree_LHGDN |
Squamous cell carcinoma of oropharynx | 0.006514605 | 24 | 1 | BeFree |
Low Grade Squamous Intraepithelial Neoplasia | 0.006514605 | 24 | 0 | BeFree |
oligodendroglioma | 0.00643866 | 15 | 0 | BeFree_GAD |
Fibroid Tumor | 0.006263026 | 5 | 0 | BeFree_LHGDN |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.006253095 | 13 | 0 | BeFree_LHGDN |
Hepatocarcinogenesis | 0.006243163 | 23 | 0 | BeFree |
Uveal melanoma | 0.006167218 | 14 | 0 | BeFree_GAD |
Malignant Glioma | 0.005971721 | 22 | 0 | BeFree |
Prostate carcinoma | 0.005971721 | 22 | 0 | BeFree |
Central neuroblastoma | 0.005971721 | 22 | 0 | BeFree |
Oropharyngeal Carcinoma | 0.005971721 | 22 | 0 | BeFree |
Epithelial ovarian cancer | 0.005895776 | 14 | 0 | BeFree_GAD |
Malignant neoplasm of prostate | 0.005700279 | 21 | 0 | BeFree |
Lymphoma, Follicular | 0.005438769 | 10 | 0 | BeFree_LHGDN |
Medulloblastoma | 0.005438769 | 10 | 0 | BeFree_LHGDN |
Mucosa-Associated Lymphoid Tissue Lymphoma | 0.005438769 | 10 | 0 | BeFree_LHGDN |
Esophageal carcinoma | 0.005428837 | 20 | 0 | BeFree |
Colon Carcinoma | 0.005428837 | 20 | 1 | BeFree |
Cholangitis, Sclerosing | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
Chondrosarcoma | 0.005167327 | 9 | 0 | BeFree_LHGDN |
Carcinoma, Small Cell | 0.005167327 | 9 | 0 | BeFree_LHGDN |
Malignant tumor of colon | 0.005157396 | 19 | 1 | BeFree |
Oropharyngeal disorders | 0.005157396 | 19 | 0 | BeFree |
Malignant Peripheral Nerve Sheath Tumor | 0.005157396 | 19 | 0 | BeFree |
Periodontitis | 0.005091382 | 1 | 0 | GAD_LHGDN |
Liver Cirrhosis | 0.005081451 | 11 | 0 | BeFree_GAD |
Neoplasms, Second Primary | 0.005005506 | 3 | 0 | BeFree_GAD |
Lymphoid leukemia | 0.004895885 | 9 | 0 | BeFree_LHGDN |
Papilloma | 0.004885954 | 18 | 0 | BeFree |
Malignant neoplasm of mouth | 0.004885954 | 18 | 0 | BeFree |
Cervical intraepithelial neoplasia grade 1 | 0.004885954 | 18 | 0 | BeFree |
Osteosarcoma of bone | 0.004885954 | 18 | 0 | BeFree |
HIV Infections | 0.004810009 | 10 | 0 | BeFree_GAD |
Brain Ischemia | 0.004734064 | 2 | 0 | GAD |
Head and Neck Neoplasms | 0.004734064 | 2 | 0 | GAD |
Heart Diseases | 0.004734064 | 2 | 0 | GAD |
Hypercholesterolemia, Familial | 0.004734064 | 2 | 0 | GAD |
Malignant mesothelioma | 0.004614512 | 17 | 0 | BeFree |
Cervical intraepithelial neoplasia grade 2 | 0.004614512 | 17 | 0 | BeFree |
Chronic Lymphocytic Leukemia | 0.00434307 | 16 | 0 | BeFree |
Human papilloma virus infection | 0.00434307 | 16 | 0 | BeFree |
Endometrial Carcinoma | 0.00434307 | 16 | 0 | BeFree |
Malignant Pleural Mesothelioma | 0.00434307 | 16 | 0 | BeFree |
Pancreatic Ductal Adenocarcinoma | 0.00434307 | 16 | 0 | BeFree |
Non-Neoplastic Disorder | 0.00434307 | 16 | 0 | BeFree |
Neuroectodermal Tumor, Primitive | 0.00408156 | 5 | 0 | BeFree_LHGDN |
Adenocarcinoma of pancreas | 0.004071628 | 15 | 0 | BeFree |
Leukemogenesis | 0.004071628 | 15 | 0 | BeFree |
Well Differentiated Oligodendroglioma | 0.004071628 | 15 | 0 | BeFree |
Atherosclerosis | 0.003995683 | 7 | 0 | BeFree_GAD |
leiomyosarcoma | 0.003810118 | 5 | 0 | BeFree_LHGDN |
Pleural effusion disorder | 0.003810118 | 4 | 0 | BeFree_LHGDN |
Acute leukemia | 0.003800186 | 14 | 0 | BeFree |
Small cell carcinoma of lung | 0.003800186 | 14 | 0 | BeFree |
Malignant neoplasm of oropharynx | 0.003800186 | 14 | 0 | BeFree |
Neurofibromatosis 1 | 0.003724241 | 5 | 0 | BeFree_GAD |
Carcinoma, Papillary | 0.003538676 | 3 | 0 | BeFree_LHGDN |
Endometriosis | 0.003538676 | 4 | 0 | BeFree_LHGDN |
liposarcoma | 0.003538676 | 4 | 0 | BeFree_LHGDN |
Pancreatic Diseases | 0.003538676 | 3 | 0 | BeFree_LHGDN |
Paraganglioma | 0.003538676 | 3 | 0 | BeFree_LHGDN |
Pituitary Adenoma | 0.003528744 | 13 | 0 | BeFree |
Pituitary Diseases | 0.003528744 | 13 | 0 | BeFree |
Solid tumour | 0.003528744 | 13 | 0 | BeFree |
Anaplastic Oligodendroglioma | 0.003528744 | 13 | 0 | BeFree |
Oropharynx (excludes nasopharynx) | 0.003528744 | 13 | 0 | BeFree |
Malignant Squamous Cell Neoplasm | 0.003528744 | 13 | 0 | BeFree |
Oral Cavity Carcinoma | 0.003452799 | 4 | 0 | BeFree_GAD |
Uterine Cervical Neoplasm | 0.003267234 | 3 | 0 | BeFree_LHGDN |
Neurilemmoma | 0.003267234 | 2 | 0 | BeFree_LHGDN |
Neoplasm, Residual | 0.003267234 | 2 | 0 | BeFree_LHGDN |
Malignant Fibrous Histiocytoma | 0.003267234 | 2 | 0 | BeFree_LHGDN |
Leukemia, T-Cell | 0.003257302 | 12 | 0 | BeFree |
Intraepithelial Neoplasia | 0.003257302 | 12 | 0 | BeFree |
precancerous lesions | 0.003257302 | 12 | 0 | BeFree |
Precursor B-cell lymphoblastic leukemia | 0.003257302 | 12 | 0 | BeFree |
Familial Atypical Mole Melanoma Syndrome | 0.003257302 | 12 | 0 | BeFree |
Experimental Organism Basal Cell Carcinoma | 0.003257302 | 12 | 2 | BeFree |
Vascular Diseases | 0.003181358 | 4 | 0 | BeFree_GAD |
gallbladder neoplasm | 0.002995792 | 2 | 0 | BeFree_LHGDN |
keratoacanthoma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Leukoplakia | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Neurofibromatoses | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Papillomavirus Infections | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Idiopathic Pulmonary Fibrosis | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Familial Atypical Multiple Mole-Melanoma | 0.002985861 | 11 | 0 | BeFree |
Laryngeal Squamous Cell Carcinoma | 0.002985861 | 11 | 0 | BeFree |
Vulval intraepithelial neoplasia | 0.002985861 | 11 | 0 | BeFree |
Ewings sarcoma | 0.002985861 | 11 | 0 | BeFree |
High Grade Cervical Intraepithelial Neoplasia | 0.002985861 | 11 | 0 | BeFree |
MYELODYSPLASTIC SYNDROME | 0.002909916 | 3 | 0 | BeFree_GAD |
Metaplasia | 0.00272435 | 1 | 0 | LHGDN |
Multiple Endocrine Neoplasia | 0.00272435 | 1 | 0 | LHGDN |
Nephritis | 0.00272435 | 1 | 0 | LHGDN |
Parkinson Disease | 0.00272435 | 1 | 0 | LHGDN |
Teratoma | 0.00272435 | 1 | 0 | LHGDN |
Pituitary-dependent Cushing's disease | 0.00272435 | 1 | 0 | LHGDN |
Adenomatous Polyposis Coli | 0.002714419 | 10 | 0 | BeFree |
Anaplastic astrocytoma | 0.002714419 | 10 | 0 | BeFree |
Thyroid carcinoma | 0.002714419 | 10 | 0 | BeFree |
Alzheimer's Disease | 0.002638474 | 2 | 0 | BeFree_GAD |
Diabetes Mellitus, Insulin-Dependent | 0.002638474 | 2 | 1 | BeFree_GAD |
Leukoplakia, Oral | 0.002638474 | 2 | 0 | BeFree_GAD |
Chronic Obstructive Airway Disease | 0.002638474 | 2 | 0 | BeFree_GAD |
Cystadenocarcinoma, Serous | 0.002638474 | 2 | 0 | BeFree_GAD |
Melanoma, Amelanotic | 0.002638474 | 1 | 0 | BeFree_GAD |
Malignant neoplasm of skin | 0.002442977 | 9 | 0 | BeFree |
Adenocarcinoma of lung (disorder) | 0.002442977 | 9 | 0 | BeFree |
Metastatic melanoma | 0.002442977 | 9 | 1 | BeFree |
Squamous cell carcinoma of vulva | 0.002442977 | 9 | 0 | BeFree |
Recurrent tumor | 0.002442977 | 9 | 0 | BeFree |
Aneuploidy | 0.002367032 | 1 | 0 | GAD |
Asthma | 0.002367032 | 1 | 0 | GAD |
Bile Duct Neoplasms | 0.002367032 | 1 | 0 | GAD |
Calcinosis | 0.002367032 | 1 | 0 | GAD |
Eczema | 0.002367032 | 1 | 0 | GAD |
Fetal Diseases | 0.002367032 | 1 | 0 | GAD |
Hay fever | 0.002367032 | 1 | 0 | GAD |
Hemorrhage | 0.002367032 | 1 | 0 | GAD |
Hyperglycemia | 0.002367032 | 1 | 0 | GAD |
Hypersensitivity | 0.002367032 | 1 | 0 | GAD |
Insulin Resistance | 0.002367032 | 1 | 0 | GAD |
Laryngeal neoplasm | 0.002367032 | 1 | 0 | GAD |
Lymphoma, Non-Hodgkin | 0.002367032 | 1 | 0 | GAD |
Animal Mammary Neoplasms | 0.002367032 | 1 | 0 | GAD |
Multiple Endocrine Neoplasia Type 1 | 0.002367032 | 1 | 0 | GAD |
Nasopharyngeal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Neoplasm Recurrence, Local | 0.002367032 | 1 | 0 | GAD |
Acoustic Neuroma | 0.002367032 | 1 | 0 | GAD |
Occupational Diseases | 0.002367032 | 1 | 0 | GAD |
Pharyngeal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Schizophrenia | 0.002367032 | 1 | 0 | GAD |
Starvation | 0.002367032 | 1 | 0 | GAD |
Sunburn | 0.002367032 | 1 | 0 | GAD |
Chagas Disease | 0.002367032 | 1 | 0 | GAD |
Uveal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Malnutrition | 0.002367032 | 1 | 0 | GAD |
physical function | 0.002367032 | 1 | 0 | GAD |
Hepatopulmonary Syndrome | 0.002367032 | 1 | 0 | GAD |
Chromosomal Instability | 0.002367032 | 1 | 0 | GAD |
Glucose Metabolism Disorders | 0.002367032 | 1 | 1 | GAD |
Solar Erythema | 0.002367032 | 1 | 0 | GAD |
Blast Phase | 0.002171535 | 8 | 0 | BeFree |
neurofibroma | 0.002171535 | 8 | 0 | BeFree |
Squamous cell carcinoma of lung | 0.002171535 | 8 | 0 | BeFree |
Squamous cell carcinoma of penis | 0.002171535 | 8 | 0 | BeFree |
Helicobacter pylori infection | 0.002171535 | 8 | 0 | BeFree |
Benign melanocytic nevus | 0.002171535 | 8 | 2 | BeFree |
Meningioma, benign, no ICD-O subtype | 0.002171535 | 8 | 0 | BeFree |
Malignant neoplasm of thyroid | 0.001900093 | 7 | 0 | BeFree |
Cervical dysplasia | 0.001900093 | 7 | 0 | BeFree |
Congenital chromosomal disease | 0.001900093 | 7 | 0 | BeFree |
Ependymoma | 0.001900093 | 7 | 0 | BeFree |
Hepatitis C | 0.001900093 | 7 | 0 | BeFree |
Benign Neoplasm | 0.001900093 | 7 | 1 | BeFree |
Epstein-Barr Virus Infections | 0.001900093 | 7 | 0 | BeFree |
Pilocytic Astrocytoma | 0.001900093 | 7 | 1 | BeFree |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.001900093 | 7 | 0 | BeFree |
Hematopoietic Neoplasms | 0.001900093 | 7 | 0 | BeFree |
invasive cancer | 0.001900093 | 7 | 0 | BeFree |
Skin carcinoma | 0.001900093 | 7 | 0 | BeFree |
Carcinoma in situ of uterine cervix | 0.001900093 | 7 | 0 | BeFree |
Invasive Carcinoma | 0.001900093 | 7 | 0 | BeFree |
Glioblastoma Multiforme | 0.001900093 | 7 | 0 | BeFree |
Arteriosclerosis | 0.001628651 | 6 | 0 | BeFree |
Rheumatoid Arthritis | 0.001628651 | 6 | 0 | BeFree |
Burkitt Lymphoma | 0.001628651 | 6 | 0 | BeFree |
Malignant neoplasm of endometrium | 0.001628651 | 6 | 0 | BeFree |
Monosomy | 0.001628651 | 6 | 0 | BeFree |
Pheochromocytoma | 0.001628651 | 6 | 0 | BeFree |
Psoriasis | 0.001628651 | 6 | 0 | BeFree |
Verrucous carcinoma | 0.001628651 | 6 | 0 | BeFree |
Gastric Adenocarcinoma | 0.001628651 | 6 | 0 | BeFree |
Squamous intraepithelial lesion | 0.001628651 | 6 | 0 | BeFree |
Anal intraepithelial neoplasia | 0.001628651 | 6 | 0 | BeFree |
Secondary malignant neoplasm of liver | 0.001628651 | 6 | 0 | BeFree |
Squamous cell carcinoma of skin | 0.001628651 | 6 | 0 | BeFree |
CARCINOMA OF VULVA | 0.001628651 | 6 | 0 | BeFree |
Adult Acute Lymphocytic Leukemia | 0.001628651 | 6 | 0 | BeFree |
Cirrhosis | 0.001628651 | 6 | 0 | BeFree |
Uterine Corpus Cancer | 0.001628651 | 6 | 0 | BeFree |
Urothelial Carcinoma | 0.001628651 | 6 | 0 | BeFree |
Noninfiltrating Intraductal Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Merkel cell carcinoma | 0.001357209 | 5 | 0 | BeFree |
Coronary Arteriosclerosis | 0.001357209 | 5 | 2 | BeFree |
Diabetes | 0.001357209 | 5 | 0 | BeFree |
Monoclonal Gammopathy of Undetermined Significance | 0.001357209 | 5 | 0 | BeFree |
synovial sarcoma | 0.001357209 | 5 | 0 | BeFree |
Virus Diseases | 0.001357209 | 5 | 0 | BeFree |
T-Cell Lymphoma | 0.001357209 | 5 | 0 | BeFree |
Li-Fraumeni Syndrome | 0.001357209 | 5 | 0 | BeFree |
Malignant neoplasm of gallbladder | 0.001357209 | 5 | 0 | BeFree |
Undifferentiated carcinoma | 0.001357209 | 5 | 0 | BeFree |
Germ cell tumor | 0.001357209 | 5 | 0 | BeFree |
Gallbladder Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Cervical Squamous Cell Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Squamous cell carcinoma of tonsil | 0.001357209 | 5 | 0 | BeFree |
Tumor necrosis | 0.001357209 | 5 | 0 | BeFree |
Malignant neoplasm of liver | 0.001357209 | 5 | 0 | BeFree |
Adenoma of large intestine | 0.001357209 | 5 | 0 | BeFree |
Cervical high grade squamous intraepithelial lesion | 0.001357209 | 5 | 0 | BeFree |
Melanocytic nevus of skin | 0.001357209 | 5 | 2 | BeFree |
Anaplasia | 0.001085767 | 4 | 0 | BeFree |
Hemangiosarcoma | 0.001085767 | 4 | 0 | BeFree |
Myeloid Leukemia | 0.001085767 | 4 | 0 | BeFree |
Leukemia, Plasma Cell | 0.001085767 | 4 | 0 | BeFree |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.001085767 | 4 | 0 | BeFree |
Lichen Sclerosus et Atrophicus | 0.001085767 | 4 | 0 | BeFree |
Liver diseases | 0.001085767 | 4 | 0 | BeFree |
Neck Neoplasms | 0.001085767 | 4 | 0 | BeFree |
Nervous System Neoplasms | 0.001085767 | 4 | 0 | BeFree |
Schistosomiasis | 0.001085767 | 4 | 0 | BeFree |
Pleural Effusion, Malignant | 0.001085767 | 4 | 0 | BeFree |
Carcinoma, Endometrioid | 0.001085767 | 4 | 0 | BeFree |
Malignant Childhood Neoplasm | 0.001085767 | 4 | 0 | BeFree |
Liver and Intrahepatic Biliary Tract Carcinoma | 0.001085767 | 4 | 0 | BeFree |
T-cell childhood acute lymphoblastic leukemia | 0.001085767 | 4 | 0 | BeFree |
Hyperplastic Polyp | 0.001085767 | 4 | 0 | BeFree |
Malignant neoplasm of vulva | 0.001085767 | 4 | 0 | BeFree |
Tonsillar Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Hereditary Malignant Neoplasm | 0.001085767 | 4 | 0 | BeFree |
Epithelioma | 0.001085767 | 4 | 0 | BeFree |
Renal carcinoma | 0.001085767 | 4 | 0 | BeFree |
Rash and Dermatitis Adverse Event Associated with Chemoradiation | 0.001085767 | 4 | 0 | BeFree |
Adenocarcinoma, Endometrioid | 0.001085767 | 4 | 0 | BeFree |
Carcinoid Tumor | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of larynx | 0.000814326 | 3 | 0 | BeFree |
Mucinous Adenocarcinoma | 0.000814326 | 3 | 0 | BeFree |
Cardiovascular Diseases | 0.000814326 | 3 | 3 | BeFree |
Uterine Cervicitis | 0.000814326 | 3 | 0 | BeFree |
Cervix Diseases | 0.000814326 | 3 | 0 | BeFree |
Primary biliary cirrhosis | 0.000814326 | 3 | 0 | BeFree |
Chordoma | 0.000814326 | 3 | 0 | BeFree |
Cystadenoma | 0.000814326 | 3 | 0 | BeFree |
Endometrial Hyperplasia | 0.000814326 | 3 | 0 | BeFree |
Fibrosarcoma | 0.000814326 | 3 | 0 | BeFree |
Gastrinoma | 0.000814326 | 3 | 0 | BeFree |
Gastritis | 0.000814326 | 3 | 0 | BeFree |
Cardiac Arrest | 0.000814326 | 3 | 0 | BeFree |
insulinoma | 0.000814326 | 3 | 0 | BeFree |
Lung diseases | 0.000814326 | 3 | 0 | BeFree |
Neurofibromatosis 2 | 0.000814326 | 3 | 0 | BeFree |
Preleukemia | 0.000814326 | 3 | 0 | BeFree |
Uterine Fibroids | 0.000814326 | 3 | 0 | BeFree |
High Grade Lymphoma (neoplasm) | 0.000814326 | 3 | 0 | BeFree |
Chronic gastritis | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of nasopharynx | 0.000814326 | 3 | 0 | BeFree |
Agenesis of corpus callosum | 0.000814326 | 3 | 0 | BeFree |
Follicular adenoma | 0.000814326 | 3 | 0 | BeFree |
Glandular Neoplasms | 0.000814326 | 3 | 0 | BeFree |
Ki-1+ Anaplastic Large Cell Lymphoma | 0.000814326 | 3 | 0 | BeFree |
Teratocarcinoma | 0.000814326 | 3 | 0 | BeFree |
Mucoepidermoid Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Carcinoma, Large Cell | 0.000814326 | 3 | 0 | BeFree |
Inverted Papilloma | 0.000814326 | 3 | 0 | BeFree |
Neuroendocrine Tumors | 0.000814326 | 3 | 0 | BeFree |
Cancer of Nasopharynx | 0.000814326 | 3 | 0 | BeFree |
Anaplastic thyroid carcinoma | 0.000814326 | 3 | 0 | BeFree |
Malignant Meningioma | 0.000814326 | 3 | 0 | BeFree |
Parathyroid Adenoma | 0.000814326 | 3 | 0 | BeFree |
Cervical Adenocarcinoma | 0.000814326 | 3 | 0 | BeFree |
Condyloma | 0.000814326 | 3 | 0 | BeFree |
Papillary squamous cell carcinoma | 0.000814326 | 3 | 0 | BeFree |
Adenocarcinoma in Situ | 0.000814326 | 3 | 0 | BeFree |
Carcinoma ex pleomorphic adenoma | 0.000814326 | 3 | 0 | BeFree |
Intrahepatic Cholangiocarcinoma | 0.000814326 | 3 | 0 | BeFree |
Stage 0 Skin Melanoma | 0.000814326 | 3 | 0 | BeFree |
Penile intraepithelial neoplasia | 0.000814326 | 3 | 0 | BeFree |
Gastric lymphoma | 0.000814326 | 3 | 0 | BeFree |
Squamous cell carcinoma of tongue | 0.000814326 | 3 | 0 | BeFree |
Primary sclerosing cholangitis | 0.000814326 | 3 | 0 | BeFree |
Poorly differentiated carcinoma | 0.000814326 | 3 | 0 | BeFree |
Penis carcinoma | 0.000814326 | 3 | 0 | BeFree |
Basaloid squamous cell carcinoma | 0.000814326 | 3 | 0 | BeFree |
Hereditary Nonpolyposis Colorectal Cancer | 0.000814326 | 3 | 0 | BeFree |
Pleural Mesothelioma | 0.000814326 | 3 | 0 | BeFree |
Primary Lesion | 0.000814326 | 3 | 0 | BeFree |
Low Grade Cervical Squamous Intraepithelial Neoplasia | 0.000814326 | 3 | 0 | BeFree |
Secondary Glioblastoma | 0.000814326 | 3 | 0 | BeFree |
Ductal Breast Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Neoplasms, Intracranial | 0.000814326 | 3 | 0 | BeFree |
Invasive Skin Melanoma | 0.000814326 | 3 | 0 | BeFree |
LATERAL MENINGOCELE SYNDROME | 0.000814326 | 3 | 0 | BeFree |
Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 0.000814326 | 3 | 0 | BeFree |
Triple Negative Breast Neoplasms | 0.000814326 | 3 | 0 | BeFree |
High grade serous carcinoma | 0.000814326 | 3 | 0 | BeFree |
Primary Myelofibrosis | 0.000542884 | 2 | 0 | BeFree |
Ameloblastoma | 0.000542884 | 2 | 0 | BeFree |
Aortic Aneurysm | 0.000542884 | 2 | 1 | BeFree |
Arthritis, Adjuvant-Induced | 0.000542884 | 2 | 0 | BeFree |
Ataxia Telangiectasia | 0.000542884 | 2 | 0 | BeFree |
Rectal Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Condylomata Acuminata | 0.000542884 | 2 | 0 | BeFree |
Diabetic Nephropathy | 0.000542884 | 2 | 1 | BeFree |
granulosa cell tumor | 0.000542884 | 2 | 0 | BeFree |
Hepatitis | 0.000542884 | 2 | 0 | BeFree |
Hepatitis A | 0.000542884 | 2 | 0 | BeFree |
Hepatitis, Chronic | 0.000542884 | 2 | 0 | BeFree |
Herpes Simplex Infections | 0.000542884 | 2 | 0 | BeFree |
Keratosis | 0.000542884 | 2 | 0 | BeFree |
Hairy Cell Leukemia | 0.000542884 | 2 | 0 | BeFree |
Leukemia, Myeloid, Chronic-Phase | 0.000542884 | 2 | 0 | BeFree |
Acute Promyelocytic Leukemia | 0.000542884 | 2 | 0 | BeFree |
Lupus Erythematosus, Systemic | 0.000542884 | 2 | 0 | BeFree |
Myeloproliferative disease | 0.000542884 | 2 | 0 | BeFree |
Nephroblastoma | 0.000542884 | 2 | 0 | BeFree |
Peutz-Jeghers Syndrome | 0.000542884 | 2 | 0 | BeFree |
Plasmacytoma | 0.000542884 | 2 | 0 | BeFree |
polyps | 0.000542884 | 2 | 0 | BeFree |
Protein Deficiency | 0.000542884 | 2 | 0 | BeFree |
Pterygium | 0.000542884 | 2 | 0 | BeFree |
Seminoma | 0.000542884 | 2 | 0 | BeFree |
Soft Tissue Neoplasms | 0.000542884 | 2 | 0 | BeFree |
Xeroderma Pigmentosum | 0.000542884 | 2 | 0 | BeFree |
Immunoblastic Large-Cell Lymphoma | 0.000542884 | 2 | 0 | BeFree |
Low Grade Lymphoma (neoplasm) | 0.000542884 | 2 | 0 | BeFree |
Atrophic condition of skin | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of tongue | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of anus | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of penis | 0.000542884 | 2 | 0 | BeFree |
Secondary malignant neoplasm of lung | 0.000542884 | 2 | 0 | BeFree |
Liposarcoma, Dedifferentiated | 0.000542884 | 2 | 0 | BeFree |
Lichen Planus, Oral | 0.000542884 | 2 | 0 | BeFree |
Sarcoma, Clear Cell | 0.000542884 | 2 | 0 | BeFree |
Hepatocellular Adenoma | 0.000542884 | 2 | 0 | BeFree |
Sebaceous Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Carcinoma, Signet Ring Cell | 0.000542884 | 2 | 0 | BeFree |
Ganglioglioma | 0.000542884 | 2 | 0 | BeFree |
Adult Acute Myeloblastic Leukemia | 0.000542884 | 2 | 0 | BeFree |
Premature aging syndrome | 0.000542884 | 2 | 0 | BeFree |
Papillary thyroid carcinoma | 0.000542884 | 2 | 0 | BeFree |
Carcinoma breast stage IV | 0.000542884 | 2 | 0 | BeFree |
Non-small cell lung cancer stage I | 0.000542884 | 2 | 0 | BeFree |
recurrent childhood acute lymphoblastic leukemia | 0.000542884 | 2 | 0 | BeFree |
Anal carcinoma | 0.000542884 | 2 | 0 | BeFree |
Transitional cell carcinoma of bladder | 0.000542884 | 2 | 0 | BeFree |
Extraosseous Ewings sarcoma-primitive neuroepithelial tumor | 0.000542884 | 2 | 0 | BeFree |
stage, non-small cell lung cancer | 0.000542884 | 2 | 0 | BeFree |
Anaplastic Ependymoma | 0.000542884 | 2 | 0 | BeFree |
Primary central nervous system lymphoma | 0.000542884 | 2 | 0 | BeFree |
Benign Meningioma | 0.000542884 | 2 | 0 | BeFree |
Multiple polyps | 0.000542884 | 2 | 0 | BeFree |
Nodular melanoma | 0.000542884 | 2 | 0 | BeFree |
Myxoid chondrosarcoma | 0.000542884 | 2 | 0 | BeFree |
Histiocytic sarcoma | 0.000542884 | 2 | 0 | BeFree |
Glaucoma, Primary Open Angle | 0.000542884 | 2 | 0 | BeFree |
Angiosarcoma of liver | 0.000542884 | 2 | 0 | BeFree |
Carcinoma of anal margin | 0.000542884 | 2 | 0 | BeFree |
Vulval intraepithelial neoplasia grade 3 | 0.000542884 | 2 | 0 | BeFree |
Pleomorphic adenoma of parotid gland | 0.000542884 | 2 | 0 | BeFree |
Richter's syndrome | 0.000542884 | 2 | 0 | BeFree |
Juvenile Myelomonocytic Leukemia | 0.000542884 | 2 | 0 | BeFree |
Chromosome 9, trisomy | 0.000542884 | 2 | 0 | BeFree |
Recurrent Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Tongue Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Malignant melanoma of eye | 0.000542884 | 2 | 0 | BeFree |
Lymphoid neoplasm | 0.000542884 | 2 | 0 | BeFree |
Hereditary Breast and Ovarian Cancer Syndrome | 0.000542884 | 2 | 0 | BeFree |
Ewings sarcoma-primitive neuroectodermal tumor (PNET) | 0.000542884 | 2 | 0 | BeFree |
Dissecting aneurysm of the thoracic aorta | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of kidney | 0.000542884 | 2 | 0 | BeFree |
cervical cancer squamous cell | 0.000542884 | 2 | 0 | BeFree |
Biliary Tract Cancer | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm tonsil | 0.000542884 | 2 | 0 | BeFree |
Chromosome 10, monosomy 10q | 0.000542884 | 2 | 4 | BeFree |
Spots on skin | 0.000542884 | 2 | 0 | BeFree |
Arteriopathic disease | 0.000542884 | 2 | 0 | BeFree |
Invasive breast carcinoma | 0.000542884 | 2 | 0 | BeFree |
Carcinogenicity | 0.000542884 | 2 | 0 | BeFree |
Mycosis fungoides/Sezary syndrome NOS | 0.000542884 | 2 | 0 | BeFree |
Ischemic stroke | 0.000542884 | 2 | 2 | BeFree |
Ductal Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Solitary fibrous tumor | 0.000542884 | 2 | 0 | BeFree |
Primary cutaneous B-cell lymphoma | 0.000542884 | 2 | 0 | BeFree |
Primary Effusion Lymphoma | 0.000542884 | 2 | 0 | BeFree |
Single tumor | 0.000542884 | 2 | 0 | BeFree |
Pancreatic intraepithelial neoplasia | 0.000542884 | 2 | 0 | BeFree |
Blastic plasmacytoid dendritic cell neoplasm | 0.000542884 | 2 | 0 | BeFree |
Melanocytic neoplasm | 0.000542884 | 2 | 0 | BeFree |
ACTH-Secreting Pituitary Adenoma | 0.000542884 | 2 | 0 | BeFree |
Atypical Ductal Breast Hyperplasia | 0.000542884 | 2 | 0 | BeFree |
Infiltrating Cervical Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Primary Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Carcinoma of urinary bladder, superficial | 0.000542884 | 2 | 0 | BeFree |
Differentiated Thyroid Gland Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Anal squamous cell carcinoma | 0.000542884 | 2 | 0 | BeFree |
Primary Glioblastoma | 0.000542884 | 2 | 0 | BeFree |
Malignant Conversion | 0.000542884 | 2 | 0 | BeFree |
Skin Carcinogenesis | 0.000542884 | 2 | 0 | BeFree |
Smoldering myeloma | 0.000542884 | 2 | 0 | BeFree |
Benign Prostatic Hyperplasia | 0.000542884 | 2 | 0 | BeFree |
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder) | 0.000542884 | 2 | 3 | BeFree |
Familial primary gastric lymphoma | 0.000542884 | 2 | 0 | BeFree |
Ulnar-mammary syndrome | 0.000542884 | 2 | 0 | BeFree |
Wolf-Hirschhorn Syndrome | 0.000542884 | 2 | 0 | BeFree |
Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Mammary adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Amyotrophic Lateral Sclerosis | 0.000271442 | 1 | 0 | BeFree |
Anemia | 0.000271442 | 1 | 0 | BeFree |
Anxiety Disorders | 0.000271442 | 1 | 0 | BeFree |
Arthritis | 0.000271442 | 1 | 0 | BeFree |
Tooth Attrition | 0.000271442 | 1 | 0 | BeFree |
Autoimmune Diseases | 0.000271442 | 1 | 0 | BeFree |
Behcet Syndrome | 0.000271442 | 1 | 0 | BeFree |
Branchioma | 0.000271442 | 1 | 0 | BeFree |
Brenner Tumor | 0.000271442 | 1 | 0 | BeFree |
Female Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Carcinosarcoma | 0.000271442 | 1 | 0 | BeFree |
Cardiomyopathy, Dilated | 0.000271442 | 1 | 0 | BeFree |
Celiac Disease | 0.000271442 | 1 | 0 | BeFree |
Cervical polyp | 0.000271442 | 1 | 0 | BeFree |
Bile duct adenoma | 0.000271442 | 1 | 0 | BeFree |
Cholangitis | 0.000271442 | 1 | 0 | BeFree |
Crohn Disease | 0.000271442 | 1 | 0 | BeFree |
Cystitis | 0.000271442 | 1 | 0 | BeFree |
Phyllodes Tumor | 0.000271442 | 1 | 0 | BeFree |
Mental Depression | 0.000271442 | 1 | 0 | BeFree |
Depressive disorder | 0.000271442 | 1 | 0 | BeFree |
Dwarfism | 0.000271442 | 1 | 0 | BeFree |
Experimental Autoimmune Encephalomyelitis | 0.000271442 | 1 | 0 | BeFree |
Erythema Nodosum | 0.000271442 | 1 | 0 | BeFree |
Peptic Esophagitis | 0.000271442 | 1 | 0 | BeFree |
Exanthema | 0.000271442 | 1 | 0 | BeFree |
Eyelid Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Fatty Liver | 0.000271442 | 1 | 0 | BeFree |
pathologic fistula | 0.000271442 | 1 | 0 | BeFree |
Fuchs Endothelial Dystrophy | 0.000271442 | 1 | 0 | BeFree |
Gall Bladder Diseases | 0.000271442 | 1 | 0 | BeFree |
Gastritis, Atrophic | 0.000271442 | 1 | 0 | BeFree |
Glycogen Storage Disease Type VI | 0.000271442 | 1 | 0 | BeFree |
Graves Disease | 0.000271442 | 1 | 0 | BeFree |
Hamartoma | 0.000271442 | 1 | 0 | BeFree |
hemangiopericytoma | 0.000271442 | 1 | 0 | BeFree |
Herpes NOS | 0.000271442 | 1 | 0 | BeFree |
Histiocytosis, Langerhans-Cell | 0.000271442 | 1 | 0 | BeFree |
Huntington Disease | 0.000271442 | 1 | 0 | BeFree |
Pulmonary Hypertension | 0.000271442 | 1 | 0 | BeFree |
Seborrheic keratosis | 0.000271442 | 1 | 0 | BeFree |
Kidney Diseases | 0.000271442 | 1 | 0 | BeFree |
Tuberculoid leprosy | 0.000271442 | 1 | 0 | BeFree |
Acute monocytic leukemia | 0.000271442 | 1 | 0 | BeFree |
Alcoholic Liver Diseases | 0.000271442 | 1 | 0 | BeFree |
Lymphatic Metastasis | 0.000271442 | 1 | 0 | BeFree |
Reticulosarcoma | 0.000271442 | 1 | 0 | BeFree |
Waldenstrom Macroglobulinemia | 0.000271442 | 1 | 0 | BeFree |
Metabolic Diseases | 0.000271442 | 1 | 0 | BeFree |
Microphthalmos | 0.000271442 | 1 | 0 | BeFree |
Multiple Sclerosis | 0.000271442 | 1 | 0 | BeFree |
Myasthenia Gravis | 0.000271442 | 1 | 0 | BeFree |
Oropharyngeal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Pancreatitis | 0.000271442 | 1 | 0 | BeFree |
Extra-Adrenal Paraganglioma | 0.000271442 | 1 | 0 | BeFree |
Penile Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Periodontitis, Juvenile | 0.000271442 | 1 | 0 | BeFree |
Polycythemia Vera | 0.000271442 | 1 | 0 | BeFree |
Pulmonary Emphysema | 0.000271442 | 1 | 0 | BeFree |
Rectal polyp | 0.000271442 | 1 | 0 | BeFree |
Sebaceous Gland Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Silicosis | 0.000271442 | 1 | 0 | BeFree |
Dermatologic disorders | 0.000271442 | 1 | 0 | BeFree |
Supratentorial Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Testicular Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Tuberous Sclerosis | 0.000271442 | 1 | 0 | BeFree |
Unipolar Depression | 0.000271442 | 1 | 0 | BeFree |
Urologic Diseases | 0.000271442 | 1 | 0 | BeFree |
Malignant Vaginal Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Hallopeau-Siemens Disease | 0.000271442 | 1 | 0 | BeFree |
Ichthyosis, X-Linked | 0.000271442 | 1 | 0 | BeFree |
Severe Combined Immunodeficiency | 0.000271442 | 1 | 0 | BeFree |
Gestational Diabetes | 0.000271442 | 1 | 6 | BeFree |
Neurofibrillary degeneration (morphologic abnormality) | 0.000271442 | 1 | 0 | BeFree |
Chronic cholecystitis | 0.000271442 | 1 | 0 | BeFree |
Rous Sarcoma | 0.000271442 | 1 | 0 | BeFree |
Sicca Syndrome | 0.000271442 | 1 | 0 | BeFree |
Congenital heart disease | 0.000271442 | 1 | 0 | BeFree |
Hypopharyngeal Cancer | 0.000271442 | 1 | 0 | BeFree |
Uterine Cancer | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of brain | 0.000271442 | 1 | 0 | BeFree |
Autoimmune thyroid disease | 0.000271442 | 1 | 0 | BeFree |
Glomerulosclerosis (disorder) | 0.000271442 | 1 | 0 | BeFree |
Microinvasive tumor | 0.000271442 | 1 | 0 | BeFree |
Carcinoma, Spindle-Cell | 0.000271442 | 1 | 0 | BeFree |
Thymic Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Hepatoblastoma | 0.000271442 | 1 | 0 | BeFree |
Fibroadenoma | 0.000271442 | 1 | 0 | BeFree |
Alveolar rhabdomyosarcoma | 0.000271442 | 1 | 0 | BeFree |
Germinoma | 0.000271442 | 1 | 0 | BeFree |
Follicular thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
Carcinoma, Neuroendocrine | 0.000271442 | 1 | 0 | BeFree |
Cystadenocarcinoma, Mucinous | 0.000271442 | 1 | 0 | BeFree |
Cystadenoma, Serous | 0.000271442 | 1 | 0 | BeFree |
Mucoepidermoid Tumor | 0.000271442 | 1 | 0 | BeFree |
gliosarcoma | 0.000271442 | 1 | 0 | BeFree |
childhood rhabdomyosarcoma | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of unknown primary | 0.000271442 | 1 | 0 | BeFree |
Metastatic malignant neoplasm to brain | 0.000271442 | 1 | 0 | BeFree |
Chondromyxoid fibroma | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of female breast | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of the vagina | 0.000271442 | 1 | 0 | BeFree |
Fibrosis, Liver | 0.000271442 | 1 | 0 | BeFree |
Interstitial fibrosis | 0.000271442 | 1 | 0 | BeFree |
Hepatitis, Autoimmune | 0.000271442 | 1 | 0 | BeFree |
Dyslipidemias | 0.000271442 | 1 | 1 | BeFree |
Islet Cell Tumor | 0.000271442 | 1 | 0 | BeFree |
Isochromosomes | 0.000271442 | 1 | 0 | BeFree |
Multiple tumors | 0.000271442 | 1 | 0 | BeFree |
Vagina Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Spongiotic dermatitis | 0.000271442 | 1 | 0 | BeFree |
Psoriasis vulgaris | 0.000271442 | 1 | 0 | BeFree |
Renal sclerosis with hypertension | 0.000271442 | 1 | 0 | BeFree |
Secondary pulmonary hypertension | 0.000271442 | 1 | 0 | BeFree |
Turcot syndrome (disorder) | 0.000271442 | 1 | 0 | BeFree |
Chronic Periodontitis | 0.000271442 | 1 | 0 | BeFree |
Gastric dysplasia | 0.000271442 | 1 | 0 | BeFree |
Superficial gastritis | 0.000271442 | 1 | 0 | BeFree |
Non-small cell lung cancer stage II | 0.000271442 | 1 | 0 | BeFree |
Extramedullary Plasmacytoma | 0.000271442 | 1 | 0 | BeFree |
Neuroblastoma recurrent | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of small intestine | 0.000271442 | 1 | 0 | BeFree |
Growth Hormone-Producing Pituitary Gland Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Non-small cell lung cancer metastatic | 0.000271442 | 1 | 0 | BeFree |
Gallbladder adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Small cell carcinoma of the cervix | 0.000271442 | 1 | 0 | BeFree |
Bladder Squamous Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Bladder Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Conventional (Clear Cell) Renal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
high-grade childhood cerebral astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Diffuse Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Mixed Oligodendroglioma-Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Myomatous neoplasm | 0.000271442 | 1 | 0 | BeFree |
Superficial ulcer | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma, metastatic | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma, keratinizing | 0.000271442 | 1 | 0 | BeFree |
Transitional cell carcinoma in situ | 0.000271442 | 1 | 0 | BeFree |
tubular adenomas and adenocarcinomas | 0.000271442 | 1 | 0 | BeFree |
Carcinoid tumor no ICD-O subtype | 0.000271442 | 1 | 0 | BeFree |
Superficial spreading malignant melanoma of skin | 0.000271442 | 1 | 0 | BeFree |
Proliferating Brenner Tumor | 0.000271442 | 1 | 0 | BeFree |
Pleomorphic Xanthoastrocytoma | 0.000271442 | 1 | 1 | BeFree |
Internal Carotid Artery Stenosis | 0.000271442 | 1 | 0 | BeFree |
Aortic aneurysm without mention of rupture NOS | 0.000271442 | 1 | 1 | BeFree |
Malignant melanoma of iris | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of adrenal cortex | 0.000271442 | 1 | 0 | BeFree |
Disseminated Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Carcinoma in situ of fallopian tube | 0.000271442 | 1 | 0 | BeFree |
Cervix adenomatous polyp | 0.000271442 | 1 | 0 | BeFree |
Vaginal intraepithelial neoplasia grade 1 | 0.000271442 | 1 | 0 | BeFree |
Prediabetes syndrome | 0.000271442 | 1 | 1 | BeFree |
Human T-cell lymphotrophic virus, type I [HTLV-I] | 0.000271442 | 1 | 0 | BeFree |
Hereditary hemochromatosis | 0.000271442 | 1 | 0 | BeFree |
Nijmegen Breakage Syndrome | 0.000271442 | 1 | 0 | BeFree |
Chronic rejection of renal transplant | 0.000271442 | 1 | 0 | BeFree |
Poikiloderma of Kindler | 0.000271442 | 1 | 0 | BeFree |
Developmental delay (disorder) | 0.000271442 | 1 | 0 | BeFree |
Atypical meningioma | 0.000271442 | 1 | 0 | BeFree |
Post-transplant lymphoproliferative disorder | 0.000271442 | 1 | 0 | BeFree |
Follicular neoplasm | 0.000271442 | 1 | 0 | BeFree |
Plasma cell tumor, malignant | 0.000271442 | 1 | 0 | BeFree |
Sleep Apnea, Obstructive | 0.000271442 | 1 | 0 | BeFree |
Neurodegenerative Disorders | 0.000271442 | 1 | 0 | BeFree |
Hepatitis C, Chronic | 0.000271442 | 1 | 0 | BeFree |
Carotid Atherosclerosis | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of mouth | 0.000271442 | 1 | 0 | BeFree |
Costello syndrome (disorder) | 0.000271442 | 1 | 0 | BeFree |
Intraocular pressure disorder | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of larynx | 0.000271442 | 1 | 0 | BeFree |
Chemical Carcinogenesis | 0.000271442 | 1 | 0 | BeFree |
Biliary stricture | 0.000271442 | 1 | 0 | BeFree |
Infective cystitis | 0.000271442 | 1 | 0 | BeFree |
Gastro-esophageal reflux disease with esophagitis | 0.000271442 | 1 | 0 | BeFree |
Progressive Neoplastic Disease | 0.000271442 | 1 | 1 | BeFree |
Locally Advanced Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Lesion of stomach | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of gastrointestinal tract | 0.000271442 | 1 | 0 | BeFree |
extranodal lymphoma | 0.000271442 | 1 | 0 | BeFree |
Bile duct carcinoma | 0.000271442 | 1 | 0 | BeFree |
anal cancer squamous cell | 0.000271442 | 1 | 0 | BeFree |
gastritis h pylori | 0.000271442 | 1 | 0 | BeFree |
Brain Tumor, Primary | 0.000271442 | 1 | 0 | BeFree |
Primary malignant neoplasm of brain | 0.000271442 | 1 | 0 | BeFree |
Basal Cell Cancer | 0.000271442 | 1 | 0 | BeFree |
psychological distress | 0.000271442 | 1 | 0 | BeFree |
Pineal germinoma | 0.000271442 | 1 | 0 | BeFree |
Pancreatic adenocarcinoma metastatic | 0.000271442 | 1 | 0 | BeFree |
Borderline ovarian tumour | 0.000271442 | 1 | 0 | BeFree |
Dedifferentiated chondrosarcoma | 0.000271442 | 1 | 0 | BeFree |
Ewing's tumour localised | 0.000271442 | 1 | 0 | BeFree |
Hyperkeratosis | 0.000271442 | 1 | 0 | BeFree |
Gastric hyperplastic polyp | 0.000271442 | 1 | 0 | BeFree |
Metastatic Prostate Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Salivary gland carcinoma | 0.000271442 | 1 | 0 | BeFree |
Polyomavirus Infections | 0.000271442 | 1 | 0 | BeFree |
Plasma cell dyscrasia | 0.000271442 | 1 | 0 | BeFree |
Persistent infection | 0.000271442 | 1 | 0 | BeFree |
Large cell neuroendocrine carcinoma | 0.000271442 | 1 | 0 | BeFree |
Traditional Serrated Adenoma | 0.000271442 | 1 | 0 | BeFree |
Metanephric adenoma | 0.000271442 | 1 | 0 | BeFree |
Intracortical osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
Major Depressive Disorder | 0.000271442 | 1 | 0 | BeFree |
Familial multiple trichoepitheliomata | 0.000271442 | 1 | 0 | BeFree |
Avellino corneal dystrophy | 0.000271442 | 1 | 0 | BeFree |
Chronic leukemia (category) | 0.000271442 | 1 | 0 | BeFree |
Chronic myeloproliferative disorder | 0.000271442 | 1 | 0 | BeFree |
Therapy-related myelodysplastic syndrome | 0.000271442 | 1 | 0 | BeFree |
Salivary duct carcinoma | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of large intestine | 0.000271442 | 1 | 0 | BeFree |
Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | 0.000271442 | 1 | 0 | BeFree |
Brain Stem Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Cervical Squamous Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Flat Ductal Epithelial Atypia of the Breast | 0.000271442 | 1 | 0 | BeFree |
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Hepatitis B Virus-Related Hepatocellular Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Hereditary Non-Polyposis Colon Cancer Type 2 | 0.000271442 | 1 | 0 | BeFree |
High Grade Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
indolent lymphoma | 0.000271442 | 1 | 0 | BeFree |
Large Cell Lung Neuroendocrine Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Mucinous Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Opisthorchis Viverrini-Related Cholangiocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Optic Nerve Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Conventional Chondrosarcoma | 0.000271442 | 1 | 0 | BeFree |
Vulvar Intraepithelial Neoplasia, Differentiated Type | 0.000271442 | 1 | 0 | BeFree |
Sporadic Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Supratentorial Primitive Neuroectodermal Tumor | 0.000271442 | 1 | 0 | BeFree |
Well Differentiated Pancreatic Endocrine Tumor | 0.000271442 | 1 | 0 | BeFree |
Hypopharyngeal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Metastatic Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Chronic esophagitis | 0.000271442 | 1 | 0 | BeFree |
Cardiomyopathy, Familial Idiopathic | 0.000271442 | 1 | 0 | BeFree |
Angiogenic Switch | 0.000271442 | 1 | 0 | BeFree |
Mammary Tumorigenesis | 0.000271442 | 1 | 0 | BeFree |
Cholangiolocellular Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Ovarian Clear Cell Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Xenograft Model | 0.000271442 | 1 | 0 | BeFree |
Non-Malignant Ascites Adverse Event | 0.000271442 | 1 | 0 | BeFree |
Enchondroma | 0.000271442 | 1 | 0 | BeFree |
Colorectal Mucinous Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Colorectal Signet Ring Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | 0.000271442 | 1 | 0 | BeFree |
Pyothorax-Associated Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Retinomas (translucent, grayish retinal mass protruding into the vitreous) | 0.000271442 | 1 | 0 | BeFree |
B-CELL MALIGNANCY, LOW-GRADE | 0.000271442 | 1 | 0 | BeFree |
Biliary papillomatosis | 0.000271442 | 1 | 0 | BeFree |
Inverted Squamous Cell Papilloma | 0.000271442 | 1 | 0 | BeFree |
Low grade glioma | 0.000271442 | 1 | 0 | BeFree |
Autosomal aneuploidy | 0.000271442 | 1 | 0 | BeFree |
eyelids (symptom) | 0.000271442 | 1 | 0 | BeFree |
Triple-Negative Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Cerebral Small Vessel Diseases | 0.000271442 | 1 | 2 | BeFree |
Chronic ulcerative colitis | 0.000271442 | 1 | 0 | BeFree |
Atypical Hemolytic Uremic Syndrome | 0.000271442 | 1 | 0 | BeFree |
Cervix Intraepithelial Neoplasia Grade 3 AJCC v7 | 0.000271442 | 1 | 0 | BeFree |
Condylomatous carcinoma | 0.000271442 | 1 | 0 | BeFree |
Ischemic Cerebrovascular Accident | 0.000271442 | 1 | 2 | BeFree |
Biliary System Disorder | 0.000271442 | 1 | 0 | BeFree |
Plasmablastic lymphoma | 0.000271442 | 1 | 0 | BeFree |
Progressive cGVHD | 0.000271442 | 1 | 1 | BeFree |
Proliferative verrucous oral leukoplakia | 0.000271442 | 1 | 0 | BeFree |
Cytogenetically normal acute myeloid leukemia | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。